SavedAdd your journal

Journals / Journal of Basic and Clinical Health Sciences / 2022 / Cilt: 6 - Sayı: 3

Familial Mediterranean Fever and Paget’s Disease: Incidental or Associated?

Betül SARGIN
Pages
928–930
Publication Date
2022-09-29
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The co-existence of FMF and PD should not be forgotten.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Co-existence of Familial Mediterranean Fever(FMF) and Paget’s disease (PD)is very rare.
📊
Key Findings & Data:A 62-year old male patient admitted with complaint of chronic low back pain and weight loss.
💡
Conclusion & Impact:The co-existence of FMF and PD should not be forgotten.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Familial Mediterranean Fever · Paget · Incidental

Abstract

Co-existence of Familial Mediterranean Fever(FMF) and Paget’s disease (PD)is very rare. In this paper, we aimed to present a case of FMF patient presenting with PD. A 62-year old male patient admitted with complaint of chronic low back pain and weight loss. An increased uptake at pelvis which was reported as paget metabolic bone disease was identified in bone scintigraphy. An infusion of 5 mg of zoledronic acid, calcium and Vitamin D treatments were administered. Paget’s disease (PD)is a rare condition in patients with FMF. The co-existence of FMF and PD should not be forgotten.

🔖

Cite This Article

SARGIN, B. (2022). Familial Mediterranean Fever and Paget’s Disease: Incidental or Associated?. Journal of Basic and Clinical Health Sciences, Cilt: 6 - Sayı: 3, 928–930. https://ajindex.com/articles/675416

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Almeida de Jesus A, Goldbach-Mansky R. Monogenic autoinflammatory diseases: concept and clinical manifestations. Clin. Immunol 2013;147:155-174
  2. Portincasa P. Colchicine, Biologic Agents and More for the Treatment of Familial Mediterranean Fever. The Old, the New, and the Rare. Curr Med Chem 2016;23:60-86
  3. Galson DL, Roodman GD. Pathobiology of Paget's disease of bone. J Bone Metabol 2014;21:85-98
  4. Eekhoff EW, Karperien M, Houtsma D, et al. Familial Paget's disease in The Netherlands: occurrence, identification of new mutations in the sequestosome 1 gene, and their clinical associations. Arthritis Rheum 2004;50:1650-1654
  5. Albagha OM. Genetics of Paget's disease of bone. Bonekey Rep 2015;4:756
  6. Mor A, Shinar Y, Zaks N, et al. Evaluation of disease severity in familial Mediterranean fever. Semin Arthritis Rheum 2005;35:57-64
  7. Appelman-Dijkstra NM, Papapoulos SE. Paget's disease of bone. Best Pract Res Clin Endocrinol Metab 2018;32:657-668
  8. Singer FR, Bone HG, Hosking DJ, et al. Paget’s disease of bone: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2014;99:4408-4422
  9. Josse RB, Hanley DA, Kendler D, et al. Diagnosis and treatment of Paget’s disease of bone. Clin Invest Med 2007;30:E210-E223
  10. Cundy T, Maslowski K, Grey A, et al. Durability of response to zoledronate treatment and competing mortality in Paget's disease of bone. J Bone Miner Res 2017; 32:753-756
  11. Walsh JP: Paget’s disease of bone. Med J Aust 2004;181:262-265
  12. Chae JJ, Wood G, Richard K, et al. The familial Mediterranean fever protein, pyrin, is cleaved by caspase-1 and activates NF-kappaB through its N-terminal fragment. Blood 2008;112:1794-1803.